Dark
Light
Today: July 10, 2024
July 10, 2024
1 min read

BioNJ partners with Tech Council Ventures to drive innovative life sciences


TLDR:

Key Points:

  • BioNJ collaborates with Tech Council Ventures to boost life sciences innovation in New Jersey.
  • The strategic partnership aims to accelerate and facilitate life sciences deals.

In a recent announcement, BioNJ, a trade association dedicated to fostering the life sciences ecosystem in New Jersey, revealed a strategic collaboration with Tech Council Ventures. The goal of this partnership is to accelerate and facilitate life sciences deals by leveraging the strengths and connections of the BioNJ community and ecosystem members. Tech Council Ventures, a venture capital firm based in Summit, New Jersey, focuses on investing in early-stage, high-growth technology companies in the Mid-Atlantic region. The collaboration between BioNJ and Tech Council Ventures will support and drive innovation in the life sciences sector, including digital health, biotech, medical devices, and therapeutics companies.

The collaboration between BioNJ and Tech Council Ventures is expected to create robust opportunities for early-stage companies to thrive and expand in New Jersey. By combining BioNJ’s network and commitment to patient access with Tech Council Ventures’ investment expertise, innovative companies in the life sciences sector will benefit greatly. Debbie Hart, President and CEO of BioNJ, expressed excitement about the collaboration, highlighting the mission of building a dynamic life sciences ecosystem in New Jersey. Jim Gunton, Managing Partner at Tech Council Ventures, also emphasized the alignment of their mission with BioNJ’s goals and the potential for innovative companies to grow and succeed through this collaboration.

This strategic partnership marks a significant step in fostering innovation and supporting the growth of early-stage companies in the life sciences sector. With a focus on creating opportunities for companies to thrive and ensuring patients have access to groundbreaking advancements, BioNJ and Tech Council Ventures are poised to make a positive impact on the life sciences industry in New Jersey.


Previous Story

Captions secures $60M in latest funding round

Latest from Blog

Captions secures $60M in latest funding round

TLDR: Captions raises $60M in Series C funding at a $500M valuation Investors include Index Ventures, Kleiner Perkins, Andreessen Horowitz, and others Captions, a NYC-based generative video creation and editing platform, has
Go toTop